acridines has been researched along with Cancer of Prostate in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, E; Bujak, P; Kasprzak, A; Kowalczyk, A; Kowalik, P; Nowicka, AM; Paluszkiewicz, E; Pilch, J | 1 |
| Chao, SW; Guh, JH; Hsu, JL; Huang, WJ; Li, TK; Liu, SP; Pan, SL; Yang, YC; Yu, CC | 1 |
| Ho, HY; Su, TL; Wu, YC; Yen, WY; Yih, LH | 1 |
| Bolger, GB; De Souza, PL; Fujimori, M; Khoo, KS; Lim, R; North, S; Phillips, J; Spiridonidis, H | 1 |
| Corcoran, C; Devery, A; Dowling, C; Fan, Y; Fitzpatrick, JM; Gallagher, WM; Mulrane, L; O'Connor, D; O'Connor, R; O'Driscoll, L; O'Neill, AJ; Prencipe, M; Rani, S; Watson, RW | 1 |
| Dzierzbicka, K; Kołodziejczyk, AM | 1 |
| Bailly, C; Chackal, S; Facompré, M; Goossens, JF; Hénichart, JP; Houssin, R; Pommery, N | 1 |
| Chackal, S; Henichart, JP; Houssin, R; Pommery, N | 1 |
| Incles, CM; Kelland, LR; Kempski, H; Koehler, H; Neidle, S; Schultes, CM | 1 |
| Amantini, C; Antonini, I; Lucciarini, R; Magnano, A; Santoni, G; Sparapani, S | 1 |
| Gambertoglio, JG; Jayewardene, AL; Santoro, JE | 1 |
| Ashizawa, T; Gomi, K; Okabe, M; Shimizu, M | 1 |
| Fippin, LJ; Small, EJ; Whisenant, SP | 1 |
| Adelstein, SJ; Fayad, F; Kassis, AI; Kinsey, BM; Venkateshan, CN | 1 |
| Nilsson, S; Trulson, A; Venge, P | 1 |
3 trial(s) available for acridines and Cancer of Prostate
| Article | Year |
|---|---|
A phase II trial of weekly i.v. KW-2170 in advanced castrate-resistant prostate cancer.
Topics: Acridines; Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Castration; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Pyrazoles; Quality of Life; Survival Rate; Treatment Outcome | 2010 |
High-performance liquid chromatographic determination of pyrazoloacridine, a nitro-9-methoxyacridine anticancer agent, in human plasma.
Topics: Acridines; Antineoplastic Agents; Chromatography, High Pressure Liquid; Circadian Rhythm; Drug Stability; Freezing; Humans; Infusions, Intravenous; Male; Osmolar Concentration; Prostatic Neoplasms; Pyrazoles; Reproducibility of Results; Sensitivity and Specificity; Temperature; Time Factors | 1997 |
Pyrazoloacridine for the treatment of hormone-refractory prostate cancer.
Topics: Acridines; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Survival Analysis | 1998 |
12 other study(ies) available for acridines and Cancer of Prostate
| Article | Year |
|---|---|
Foliate-Targeting Quantum Dots-
Topics: Acridines; Antineoplastic Agents; beta-Cyclodextrins; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Folic Acid; Humans; Lung; Lung Neoplasms; Male; Nanoconjugates; Nanostructures; Prostate; Prostatic Neoplasms; Quantum Dots | 2022 |
A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Topics: Acridines; Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cells, Cultured; DNA Damage; DNA Repair; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Drugs, Investigational; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Male; Mice, Nude; Neoplasm Proteins; Prostate; Prostatic Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Burden; Vorinostat; Xenograft Model Antitumor Assays | 2014 |
Glyfoline induces mitotic catastrophe and apoptosis in cancer cells.
Topics: Acridines; Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Female; HeLa Cells; Humans; Lung Neoplasms; Male; Mice; Microtubules; Mitosis; Neoplasms; Prostatic Neoplasms; Tubulin | 2010 |
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
Topics: Acridines; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; ATP Binding Cassette Transporter, Subfamily B, Member 1; beta-Galactosidase; Cell Line, Tumor; Cell Survival; Cellular Senescence; Docetaxel; Drug Resistance, Neoplasm; Gene Expression; Gene Expression Profiling; Genes, Reporter; Humans; Luciferases, Renilla; Male; Molecular Targeted Therapy; NF-kappa B; Nitriles; Prostatic Neoplasms; Sulfones; Taxoids; Tetrahydroisoquinolines | 2011 |
Synthesis and antitumor activity of conjugates of muramyldipeptide or normuramyldipeptide with hydroxyacridine/acridone derivatives.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Acridines; Acridones; Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Lymphoma, AIDS-Related; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
Highly cytotoxic benzo[c]pyrido[2,3,4-kl]acridines.
Topics: Acridines; Animals; Antineoplastic Agents; Cattle; DNA; DNA Topoisomerases; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Male; Nucleic Acid Conformation; Nucleic Acid Denaturation; Prostatic Neoplasms; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2003 |
Design, synthesis and pharmacological evaluation of new anticancer fused pentacycles.
Topics: Acridines; Antineoplastic Agents; Cell Division; Cell Survival; Drug Design; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Male; Molecular Structure; Prostatic Neoplasms; Pyridines; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
Topics: 3T3 Cells; Acridines; Animals; Blotting, Western; Catalysis; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chromosomes; Cyclin-Dependent Kinase Inhibitor p16; DNA; G-Quadruplexes; Humans; Ligands; Male; Metaphase; Mice; Models, Chemical; Nucleic Acid Conformation; Prostatic Neoplasms; Rhodamines; Telomerase; Telomere; Time Factors; Up-Regulation | 2004 |
Synthesis and biological evaluation of new asymmetrical bisintercalators as potential antitumor drugs.
Topics: Acridines; Antineoplastic Agents; Binding, Competitive; Cell Line, Tumor; DNA; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 4 or More Rings; Humans; Intercalating Agents; Male; Prostatic Neoplasms; Solubility; Structure-Activity Relationship | 2006 |
Antitumor activity of KW-2170, a novel pyrazoloacridone derivative.
Topics: Acridines; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Doxorubicin; Drug Resistance, Multiple; Female; Fibrosarcoma; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Molecular Structure; Neoplasms; Prostatic Neoplasms; Pyrazoles; Sarcoma 180; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Synthesis and biological activity of the intercalating agent 3-acetamido-5-[123/125I]iodo-6-aminoacridine.
Topics: Acridines; DNA; Humans; In Vitro Techniques; Intercalating Agents; Iodine Radioisotopes; Isotope Labeling; Male; Proflavine; Prostatic Neoplasms | 1990 |
Lucigenin-enhanced chemiluminescence in blood is increased in cancer.
Topics: Acridines; Adult; Aged; Aged, 80 and over; Cell Separation; Female; Humans; Kidney Neoplasms; Leukocyte Count; Luminescent Measurements; Luminol; Male; Middle Aged; Monocytes; Neoplasms; Neutrophils; Prostatic Neoplasms | 1989 |